AstraZeneca Director Pushing to Tie Exec Pay to Big Growth Promises

Soriot and his team fought hard against Pfizer's £55-per-share bid, and in the process promised to send sales soaring to $45 billion by 2023. Last summer, some top shareholders suggested directly linking executive pay to progress toward those goals. And in ...
Login to comment.